CYTEK BIOSCIENCES INC's ticker is and the CUSIP is 23285D109. A total of 102 filers reported holding CYTEK BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.05 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,162,134 | -32.0% | 391,691 | +5.1% | 0.00% | 0.0% |
| Q2 2023 | $3,181,543 | +183.1% | 372,546 | +204.6% | 0.00% | – |
| Q1 2023 | $1,123,964 | +127.9% | 122,303 | +153.2% | 0.00% | – |
| Q4 2022 | $493,256 | -36.8% | 48,311 | -9.0% | 0.00% | – |
| Q3 2022 | $781,000 | +38.2% | 53,077 | +0.8% | 0.00% | – |
| Q2 2022 | $565,000 | +30.8% | 52,661 | +31.3% | 0.00% | – |
| Q1 2022 | $432,000 | – | 40,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,100,000 | $22,533,000 | 12.24% |
| Miura Global Management | 1,649,400 | $17,698,000 | 12.14% |
| RA Capital Management | 13,381,054 | $143,578,000 | 3.83% |
| HHLR ADVISORS, LTD. | 8,757,030 | $93,963,000 | 2.01% |
| PURA VIDA INVESTMENTS, LLC | 477,164 | $5,120,000 | 0.30% |
| RTW INVESTMENTS, LP | 916,838 | $9,838,000 | 0.25% |
| Glenview Capital Management | 500,000 | $5,365,000 | 0.13% |
| GSA CAPITAL PARTNERS LLP | 73,743 | $791,000 | 0.12% |
| Parkwood LLC | 42,292 | $454,000 | 0.08% |
| Point72 Asset Management, L.P. | 1,536,079 | $16,482,000 | 0.07% |